Next Quarterly Earnings
Wednesday, August 5, 2026
CW 32
Pre-Market
In 31 days
United Therapeutics Corporation is a U.S. biopharmaceutical company dedicated to developing innovative therapies for patients with life-threatening diseases. A primary focus is on lung diseases such as pulmonary arterial hypertension (PAH) and improving organ transplantation. The company researches and develops groundbreaking medicines to extend and improve the lives of its patients.